Characterization of molecular mechanisms driving Merkel cell polyomavirus oncogene transcription and tumorigenic potential.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
09
06
2023
accepted:
03
08
2023
medline:
1
9
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
epublish
Résumé
Merkel cell polyomavirus (MCPyV) is associated with approximately 80% of cases of Merkel cell carcinoma (MCC), an aggressive type of skin cancer. The incidence of MCC has tripled over the past twenty years, but there are currently very few effective targeted treatments. A better understanding of the MCPyV life cycle and its oncogenic mechanisms is needed to unveil novel strategies for the prevention and treatment of MCC. MCPyV infection and oncogenesis are reliant on the expression of the early viral oncoproteins, which drive the viral life cycle and MCPyV+ MCC tumor cell growth. To date, the molecular mechanisms regulating the transcription of the MCPyV oncogenes remain largely uncharacterized. In this study, we investigated how MCPyV early transcription is regulated to support viral infection and MCC tumorigenesis. Our studies established the roles of multiple cellular factors in the control of MCPyV gene expression. Inhibitor screening experiments revealed that the histone acetyltransferases p300 and CBP positively regulate MCPyV transcription. Their regulation of viral gene expression occurs through coactivation of the transcription factor NF-κB, which binds to the viral genome to drive MCPyV oncogene expression in a manner that is tightly controlled through a negative feedback loop. Furthermore, we discovered that small molecule inhibitors specifically targeting p300/CBP histone acetyltransferase activity are effective at blocking MCPyV tumor antigen expression and MCPyV+ MCC cell proliferation. Together, our work establishes key cellular factors regulating MCPyV transcription, providing the basis for understanding the largely unknown mechanisms governing MCPyV transcription that defines its infectious host cell tropism, viral life cycle, and oncogenic potential. Our studies also identify a novel therapeutic strategy against MCPyV+ MCC through specific blockage of MCPyV oncogene expression and MCC tumor growth.
Identifiants
pubmed: 37647312
doi: 10.1371/journal.ppat.1011598
pii: PPATHOGENS-D-23-00941
pmc: PMC10468096
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1011598Subventions
Organisme : NIAMS NIH HHS
ID : R21 AR074073
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA187718
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA174523
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI149761
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA284690
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA267803
Pays : United States
Informations de copyright
Copyright: © 2023 Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Chem Biol. 2010 May 28;17(5):471-82
pubmed: 20534345
Science. 2004 Oct 22;306(5696):704-8
pubmed: 15499023
Cancer Res. 2014 Jun 15;74(12):3332-43
pubmed: 24736545
Oncogene. 2014 May 1;33(18):2395-404
pubmed: 23686307
J Vis Exp. 2019 Feb 7;(144):
pubmed: 30799855
J Virol. 2010 Jul;84(14):7064-72
pubmed: 20444890
PLoS Pathog. 2022 Dec 27;18(12):e1011039
pubmed: 36574443
Int J Cancer. 2012 Feb 15;130(4):847-56
pubmed: 21413015
J Virol. 2009 Nov;83(21):10846-56
pubmed: 19640999
EMBO J. 2002 Dec 2;21(23):6539-48
pubmed: 12456660
Viruses. 2022 Feb 25;14(3):
pubmed: 35336880
Mol Cell. 1998 Apr;1(5):661-71
pubmed: 9660950
Cell Host Microbe. 2013 Aug 14;14(2):125-35
pubmed: 23954152
Oncogene. 2020 Jun;39(24):4770-4779
pubmed: 32366905
Exp Dermatol. 2009 Mar;18(3):193-8
pubmed: 19400830
J Clin Oncol. 2019 Mar 20;37(9):693-702
pubmed: 30726175
PLoS Pathog. 2009 Sep;5(9):e1000578
pubmed: 19750217
Curr Probl Cancer. 2010 Jan-Feb;34(1):14-37
pubmed: 20371072
Curr Opin Virol. 2015 Apr;11:38-43
pubmed: 25681708
Science. 2002 Nov 8;298(5596):1241-5
pubmed: 12424381
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7
pubmed: 18812503
J Virol. 1999 Dec;73(12):10146-57
pubmed: 10559330
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12744-9
pubmed: 23847207
J Virol. 2013 Aug;87(16):9173-88
pubmed: 23760247
Mol Cell Biol. 2011 Jul;31(13):2641-52
pubmed: 21555454
Science. 2008 Feb 22;319(5866):1096-100
pubmed: 18202256
Cell. 1983 Apr;32(4):1227-40
pubmed: 6301686
Cell. 1981 Aug;25(2):373-84
pubmed: 6269743
Viruses. 2017 Nov 17;9(11):
pubmed: 29149060
Cancer Med. 2016 Sep;5(9):2294-301
pubmed: 27431483
Nat Rev Genet. 2016 Aug;17(8):487-500
pubmed: 27346641
J Am Acad Dermatol. 2018 Mar;78(3):457-463.e2
pubmed: 29102486
Adv Cancer Res. 2010;106:1-51
pubmed: 20399955
J Virol. 2021 Jun 10;95(13):e0221120
pubmed: 33883226
Emerg Infect Dis. 2011 Aug;17(8):1371-80
pubmed: 21801612
Gene. 2001 Oct 31;278(1-2):25-31
pubmed: 11707319
Annu Rev Immunol. 2013;31:51-72
pubmed: 23157435
Nat Metab. 2022 Jun;4(6):693-710
pubmed: 35760868
FEBS Lett. 2002 Feb 20;513(1):124-8
pubmed: 11911891
Clin Cancer Res. 2018 May 1;24(9):2035-2043
pubmed: 29217527
J Am Chem Soc. 2014 Jul 2;136(26):9308-19
pubmed: 24946055
Curr Opin Virol. 2015 Oct;14:129-37
pubmed: 26447560
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
J Clin Invest. 2011 Sep;121(9):3623-34
pubmed: 21841310
Cell Host Microbe. 2016 Jun 8;19(6):775-87
pubmed: 27212661
Int J Cancer. 2009 Sep 15;125(6):1250-6
pubmed: 19499548
Annu Rev Pathol. 2012;7:123-44
pubmed: 21942528
J Biol Chem. 2003 May 23;278(21):19134-40
pubmed: 12624111
JAMA Dermatol. 2020 Aug 1;156(8):863-873
pubmed: 32492087
Mol Cancer Ther. 2020 Jul;19(7):1406-1414
pubmed: 32371576
FEBS Lett. 2006 Aug 7;580(18):4353-6
pubmed: 16844118
ACS Med Chem Lett. 2017 Dec 13;9(1):28-33
pubmed: 29348807
Int J Oncol. 2017 Dec;51(6):1860-1868
pubmed: 29075795
Basic Clin Pharmacol Toxicol. 2012 Feb;110(2):122-32
pubmed: 22103711
Cancer. 1978 Nov;42(5):2311-21
pubmed: 719609
Virology. 2013 Jan 5;435(1):118-30
pubmed: 23217622
J Virol. 2009 Dec;83(23):12118-28
pubmed: 19759150
Nature. 2010 Dec 23;468(7327):1067-73
pubmed: 20871596
PLoS Pathog. 2011 Jul;7(7):e1002161
pubmed: 21829355
J Invest Dermatol. 2015 May;135(5):1415-1424
pubmed: 25313532
PLoS Pathog. 2013;9(8):e1003558
pubmed: 23990782
Arch Dermatol. 1972 Jan;105(1):107-10
pubmed: 5009611
Nat Commun. 2017 Nov 15;8(1):1527
pubmed: 29142305
Cell. 1998 Dec 11;95(6):749-58
pubmed: 9865693
J Med Chem. 2017 Nov 22;60(22):9162-9183
pubmed: 28892380
Virology. 2009 Jan 20;383(2):183-7
pubmed: 19046593
J Clin Virol. 2011 Feb;50(2):125-9
pubmed: 21094082
J Pathol. 2009 May;218(1):48-56
pubmed: 19291712
Mol Cell Biol. 1995 May;15(5):2689-96
pubmed: 7739549
Bioeng Transl Med. 2022 Aug 22;7(3):e10394
pubmed: 36176599
Nature. 2017 Oct 5;550(7674):128-132
pubmed: 28953875
J Biol Chem. 2007 May 4;282(18):13141-5
pubmed: 17329240
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13730-13739
pubmed: 32482869
J Virol. 2023 Apr 27;97(4):e0190722
pubmed: 36946735
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1014-9
pubmed: 10655476
Am Surg. 2015 Aug;81(8):802-6
pubmed: 26215243
Cancer Discov. 2021 May;11(5):1118-1137
pubmed: 33431496
Cell Host Microbe. 2010 Jun 25;7(6):509-15
pubmed: 20542254
PLoS One. 2012;7(7):e42181
pubmed: 22860078
Theranostics. 2019 Oct 22;9(26):8344-8361
pubmed: 31754401
PLoS Pathog. 2012;8(11):e1003021
pubmed: 23144621
Mol Cell Biol. 2009 Mar;29(5):1375-87
pubmed: 19103749
PLoS Pathog. 2015 Jul 28;11(7):e1004974
pubmed: 26218535
J Virol. 2018 Mar 14;92(7):
pubmed: 29343574
Virol J. 2020 Apr 19;17(1):54
pubmed: 32306957
Cell Death Dis. 2020 Sep 11;11(9):745
pubmed: 32917859
Curr Opin Virol. 2016 Oct;20:20-27
pubmed: 27521569
Biomed Pharmacother. 2018 Oct;106:1727-1733
pubmed: 30119248
PLoS One. 2010 Jul 02;5(7):e11423
pubmed: 20625394
Genes Dev. 1993 Jul;7(7A):1266-76
pubmed: 8319912
J Virol. 2018 Jan 30;92(4):
pubmed: 29167345
Annu Rev Virol. 2020 Sep 29;7(1):289-307
pubmed: 32603631
J Am Acad Dermatol. 2008 Mar;58(3):375-81
pubmed: 18280333
J Mol Biol. 2011 Jun 17;409(4):529-42
pubmed: 21501625
J Invest Dermatol. 2014 May;134(5):1479-1481
pubmed: 24217011
Int Immunopharmacol. 2021 May;94:107458
pubmed: 33626422
J Biol Chem. 2001 Apr 27;276(17):13505-8
pubmed: 11279224
Proc Natl Acad Sci U S A. 2017 May 16;114(20):E4040-E4047
pubmed: 28461484
Viruses. 2020 Sep 24;12(10):
pubmed: 32987952
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10768-73
pubmed: 26261308